News

Advanced eClinical Training's CCMA Program Gains ACE College Credit

Advanced eClinical Training's CCMA Program Gains ACE College Credit

Advanced eClinical Training's CCMA Program Achieves ACE Approval

Advanced eClinical Training (ACT) proudly announces that its Certified Clinical Medical Assistant (CCMA) program has achieved recognition from the American Council on Education (ACE) via its Learning Evaluations program. This esteemed approval enables students to earn up to 6 college credits upon successful completion of ACT's 8-week CCMA course, paving the way for accelerated progress toward their postsecondary degrees.

Seamless Credit Transfers to Colleges

The endorsement from ACE allows students enrolled in ACT's programs to transfer their credits to various participating academic institutions with ease. This significant achievement signifies ACT's unwavering commitment to creating educational opportunities that facilitate both career advancement and academic growth.

Empowering Students in Allied Health

ACT's CCMA program is specifically designed to equip students with the essential skills and knowledge to thrive in the allied health sector. By incorporating ACE-endorsed credit pathways, ACT reinforces its dedication to supporting learners throughout their professional journeys. With a strong emphasis on quality and flexibility in education, ACT positions itself as a frontrunner in preparing students for success.

Leadership's Vision for Innovative Education

Leah Medwig, ACT's Chief Learning Officer, expresses, “This recognition from ACE is a transformative moment for Advanced eClinical Training and our students. By offering college credit for our certificate programs, we reinforce our mission to deliver innovative educational solutions that meet industry needs and support students' long-term aspirations.”

Collaboration Opportunities in Education

ACT invites colleges, universities, workforce development agencies, and employers to collaborate in creating impactful learning pathways. Leveraging ACE approval enables ACT to offer students and employees a bridge between formal training and academic achievement, ultimately enhancing workforce readiness and career success. These collaborative efforts ensure that students can effectively redeem their ACE-approved credits for further education without losing sight of their professional development goals.

Building Educational Partnerships

With ACE accreditation, ACT is setting the stage for strategic alliances with educational institutions to create flexible learning pathways. This approach allows learners to receive academic credit for prior professional training, including ACT's CCMA program, and integrate these credits into their degree pursuits.

Benefits for Educational Institutions

By partnering with ACT, universities and colleges can enjoy several advantages:

  • Improved Retention Rates: Recognizing prior learning through ACE-approved courses creates a more seamless academic experience, which can boost student satisfaction.
  • Increased Enrollment Numbers: Institutions that accept ACE credits broaden their appeal, attracting non-traditional students and expanding their enrollment base.
  • Smoother Transitions to Degree Programs: ACE-endorsed credits facilitate students' movement from certification to academic degrees, cultivating lifelong learning.

Cassidy Floyd, Director of Partnerships at ACT, commented, “This partnership opportunity with Advanced eClinical Training and ACE approval is a game-changer for colleges and universities. It allows institutions to better cater to diverse learner groups while facilitating academic progression and alignment with workforce needs.”

Advantages for Employers

Employers and healthcare organizations can leverage ACE approval as a powerful tool to enhance workforce development efforts by validating and elevating the quality of their training programs. Collaborating with ACT provides employers with the following benefits:

  • Validation of Training Quality: ACE's rigorous review process ensures that ACT's programs meet high standards, enhancing employee credential credibility.
  • Clear Competency Documentation: Employers can utilize ACE-endorsed transcripts and badges to monitor talent development, helping to pinpoint skill gaps and promote employee growth.
  • Enhanced Talent Pipelines: ACT’s ACE-approved courses provide structured training approaches that enhance workforce readiness and retention rates.

Educational institutions and employers keen on innovating learning pathways with ACT are encouraged to get in touch with Cassidy Floyd for collaboration opportunities.

About Advanced eClinical Training (ACT)

Advanced eClinical Training (ACT) serves as a national online career training school dedicated to allied health certifications. With fully online courses featuring high-definition video instruction, interactive simulations, and realistic training exercises, ACT prepares students for industry-recognized certifications. The programs are self-paced and complemented by one-on-one guidance, ensuring students have the crucial resources they need to excel.

Frequently Asked Questions

What is the ACE approval for the CCMA program?

The ACE approval allows students who complete the CCMA program to earn college credits, which can be transferred to various institutions.

How many college credits can students earn?

Students can earn up to 6 college credits upon completing the CCMA program offered by ACT.

What benefits does ACT's CCMA program offer?

It provides quality education, practical skills training, and pathways for academic progression, benefitting both students and workforce readiness.

How does ACE accreditation benefit educational institutions?

ACE accreditation helps institutions improve retention rates, attract non-traditional students, and facilitate smoother transitions from certifications to academic degrees.

Can employers benefit from ACT's ACE-approved training programs?

Yes, employers can elevate their workforce development efforts and validate the quality of training provided through ACE's endorsement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 87

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
West Virginia Water Gains: Central Grove Upgrade Begins

Updated Category News Views 98

Kickoff at Central Grove: What’s Brewing? Ever wander through Kearneysville, W.Va., and wonder what’s going on with that bustling crew near Goldenrod Drive? The folks at West Virginia American Water have kicked off groundwork for the much-anticipated Central Grove Water Treatment Plant. This, comrades, isn’t just some shiny new shed we’re talking about. Oh no,...

Continue Reading
ANDPAD Shines in Asia's 2026 Growth Company Awards

Updated Category News Views 165

AI Takes Center Stage in Construction Ever seen AI shake a dusty old industry to its core? Well, if you haven't, ANDPAD is doing just that in construction, making waves across Asia. Look, when a company like ANDPAD snags a spot in the 'NextGen Tech 30 2026,' you pay attention. That's a glitzy award for the movers and shakers in tech, and these folks are doing some serious...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 129

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Mobile Health Program Drives Down Hospital Visits

Updated Category News Views 61

The wheels are literally in motion in South Broward, with Memorial Healthcare System's Mobile Health Program taking healthcare to the doorstep of thousands. This killer initiative slashed hospital admissions by a nifty 62% among its users in 2025, and they ain't slowing down in 2026. Talk about bringing the doctor to the streets and changing lives! Healthcare On Wheels:...

Continue Reading
Kuaishou Prepares for Q3 Financial Reveals—November 19

Updated Category News Views 144

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Continue Reading
Brookdale Shows Recovery with Improved Q3 2026 Results

Updated Category News Views 25

Cracking Open Brookdale's Q3 2026 Numbers: A Mixed Bag You know, there's something oddly satisfying about net losses shrinking like a cheap wool sweater in a hot wash. Brookdale Senior Living's third quarter results show just that. We're looking at a net loss of $13.9 million, a big step up from the towering $114.7 million nosedive a year ago. Yeah, it's still a loss, but...

Continue Reading
Frederick's VFW Post Thrives with New Facility Launch

Updated Category News Views 78

The Power of Building a Legacy There I was, watching the home the VFW built not just with nails and beams, but conviction. In a world where construction and legacy often don't speak the same language, the Frederick VFW Post 3285 is flipping the script. We're looking at a story about real, tangible impact—not in the P&Ls but in actual lives. Brick by Brick: A...

Continue Reading
Sass Magazine's 2026 COZY Issue Embraces Intentional Joy

Updated Category News Views 92

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 109

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading

Top 5 Most Recently Viewed Articles

Harris & Harris Group Navigates Market Challenges as TURN Hits Low

Updated Category News Views 193

Market Challenges Impacting Harris & Harris Group In the current challenging market landscape, shares of Harris & Harris Group, Inc. (NASDAQ: TURN) have hit a 52-week low of $3.3. This investment firm, known for its venture capital endeavors, has encountered substantial difficulties over the past year, evidenced by a notable decline of 19.76%. Such a downturn reflects...

Continue Reading
Purdue Innovates Fast Lead Detection for Healthier Communities

Updated Category News Views 214

Innovative Approaches for Lead Exposure Detection Lead exposure can have serious consequences on health, and it is crucial to have effective methods for its detection. A team at Purdue University has pioneered transformative technologies that streamline the process of measuring lead exposure in blood and bone tissues. The innovations developed offer significant benefits...

Continue Reading
Devon Energy's Upcoming Fireside Chat at J.P. Morgan Conference

Updated Category News Views 195

Devon Energy Engages with Investors at J.P. Morgan Conference Devon Energy Corp. (NYSE: DVN) is gearing up for an exciting opportunity to engage directly with investors. Clay Gaspar, the company’s President and CEO, will be participating in a fireside chat at the prestigious J.P. Morgan Energy, Power, Renewables & Mining Conference. This event promises to be informative...

Continue Reading
Spanish Stock Market Dynamics: Key Highlights and Trends

Updated Category News Views 384

Recent Developments in the Spanish Stock Market The Spanish stock market experienced a downturn recently, closing lower amid notable sectoral losses. The primary sectors that faced declines included Telecoms & IT, Building & Construction, and Chemical, Petroleum & Plastic. These pullbacks adversely affected many stocks, particularly within the IBEX 35 index. IBEX 35...

Continue Reading
Oppenheimer Keeps GDEV Stock Rating Amid Growth Potential

Updated Category News Views 73

Oppenheimer Maintains Perform Rating on GDEV Inc. Oppenheimer has decided to keep its Perform rating on shares of GDEV Inc. (NASDAQ: GDEV), focusing on the exciting growth avenues being explored for the company's PG3 game. The firm notes that while PG3 currently constitutes less than 10% of GDEV's overall revenues, it is strategically placed for future expansion. Future...

Continue Reading